top of page
About
Paint is committed to advancing its delivery technology and building a pipeline of tissue-targeted therapeutics. The modular PAINTR™ discovery platform has identified targeted delivery motifs for multiple tissues.
Company Overview
Eric Springman
Co-Founder & COO
View Bio
Frank Guarnieri, PhD
Inventor, Co-Founder, & CSO
View Bio
Meet The Team
With over 20 years of collaborative experience, the Paint team brings unparalleled expertise in drug discovery and development. Uniquely positioned to develop groundbreaking technologies like PulmoPaint™, CerebroPaint™, and GastroPaint™, we are revolutionizing how medicines are delivered and retained in specific tissues.
bottom of page